Molecular Templates (MTEM) PT Lowered to $18 at Laidlaw, Following Clinical Business Update
- U.S. stocks close down on news of Biden tax proposal
- Biden To Propose Capital Gains Tax As High As 43.4% For Wealthy - Bloomberg
- Intel (INTC) Tops Q1 EPS by 24c, Offers Guidance
- Snap (SNAP) Tops Q1 EPS by 5c, DAUs were 280 million, Offers Guidance
- Credit Suisse (CS) Falls 6% on 'Unacceptable Loss' as Exposure to Archegos Grew to More Than $20 Billion, Set to Raise Over $2 Billion to Support Liquidity
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Laidlaw analyst Yale Jen lowered the price target on Molecular Templates (NASDAQ: MTEM) to $18.00 (from $20.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: UBS Upgrades EnLink Midstream, LLC (ENLC) to Buy
- Universal Forest Products (UFPI) PT Raised to $95 at Stifel
- Evolution Mining Ltd. (EVN:AU) (CAHPF) PT Raised to AUD5.15 at CLSA
Create E-mail Alert Related CategoriesAnalyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!